Quite excited to share our latest review article, “Virtual reality in drug design: Benefits, applications and industrial perspectives,” published in Current Opinion in Structural Biology. This article delves into how virtual reality (VR) is transforming structure-based drug design by enabling immersive visualization and real-time manipulation of complex molecular structures. We discuss various applications of VR in drug discovery, including its role in COVID-19 research and protein-ligand docking, and present insights from pharmaceutical industry experts on integrating VR into existing workflows. The full article is freely available.
- M. Baaden, D. R. Glowacki: Virtual reality in drug design: Benefits, applications and industrial perspectives Current Opinion in Structural Biology 92, 2025, 103044.
CC BY-NC-SA 4.0